Pre-clinical experimentation and clinical research
Pre-clinical experimentation and clinical research
Contact
Arronax Nantes > Pre-clinical experimentation and clinical research > Our publications

Our publications

  • Radiothérapie interne vectorisée alpha pour le traitement de la leucémie aigüe myéloblastique
    Sorin M, Gouard S, Marionneau-Lambot S, Eychenne R, Maingueneau C, Ligeour M, Guilloux Y, Allard M, Guérard F, Chérel M, Gaschet J
    1er congrès de la Société Française de Biologie des Radiations, St Raphaël, France, november 7-9, 2022

  • Targeted Alpha-Therapy for the treatment of Acute Myeloid Leukemia
    Sorin M, Gouard S, Marionneau-Lambot S, Eychenne R, Maingueneau C, Ligeour M, Guilloux Y, Allard M, Guérard F, Chérel M, Gaschet J
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Development and PET/CT preclinical evaluation of anti-CXCR4 antibody in triple-negative breast cancer (TNBC) murine model
    Métivier C, El Ayoubi N, Le Saëc P, Garcion E, Tripier R, Haddad F, Chérel M, Huclier S, Faivre-Chauvet A, Rbah-Vidal L
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Neutral Copper(II) TE1PA-based chelate for 64Cu-PET imaging : when an additional carboxyl group makes the difference
    Pineau J, Lima LMP, Marionneau-Lambot S, Le Saëc P, Faivre-Chauvet A, Zeevaart JR, Driver CHS, Le Bris N, Tripier R
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Tracking CXCR4 with a small synthetic organic vector : chelator conjugation, 64Cu radiolabelling and in vivo targeted-PET imaging
    Le Roy M, Le Saëc P, Chérel M, Faivre-Chauvet A, Troadec T, Tripier R
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Evaluation of peptide receptor radionuclide therapy using 225Ac-DOTATOC in a mouse model of liver metastases of pancreatic neuroendocrine tumor
    Lugat A, Marionneau-Lambot S, Gouard S, Frampas E, Faivre-Chauvet A, Morgenstern A, Bruchersteifer F, Chérel M, Kraeber-Bodéré F, Ansquer C, Gaschet J
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Targeting of circulating tumor cells in triple negative breast cancer
    Laurent N, Marionneau-Lambot S, Gouard S, Heymann D, Maingueneau C, Haddad F, Lepareur N, Guilloux Y, Chérel M
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Radiobiology of alpha emitters : development of an in vitro tumor model of targeted alpha-therapy
    Jacquet C, Oger R, Gouard S, Eychenne R, Maingueneau C, Ligeour M, Guérard F, Chérel M, Gaschet J, Guilloux Y, Allard M
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Locoregional Astatine-211 Radioimmunotherapy Targeting Syndecan-1 in a Syngeneic Glioblastoma Mouse Model
    Roncali L, Roy C, Marionneau-Lambot S, Gouard S, Eychenne R, Avril S, Guérard F, Hindré F, Chérel M, Garcion E
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma
    Nahas H, Brossard C, Vene E, Gouard S, Chérel M, Bourgeois M, Loyer P, Lepareur N, Cammas-Marion S
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

see more results